Why the study?
Does verapamil improve exercise capacity and symptomatic status in patients with hypertrophic cardiomyopathy?
Does verapamil improve exercise capacity and symptomatic status in patients with hypertrophic cardiomyopathy?
Verapamil improves exercise capacity and symptomatic status in patients with hypertrophic cardiomyopathy, offering an alternative to beta-blockers.
Answers are grounded in this paper and cite their sources.
May support verapamil in symptomatic HCM; hypothesis-generating and should not yet change practice pending RCTs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rosing et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: